| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/23/2006 | WO2006019431A2 Methods and kits for measuring adamts13/fxi complexes |
| 02/23/2006 | WO2006019429A2 Methods of identifying and using agents that increase inhibition of or resistance to hcv infection |
| 02/23/2006 | WO2006019411A2 Catalytic production of biomarkers from biological materials |
| 02/23/2006 | WO2006019407A2 Method for detecting and quantifying rare mutations/polymorphisms |
| 02/23/2006 | WO2006019388A2 Cleavable solid phases for isolating nucleic acids |
| 02/23/2006 | WO2006019387A1 Methods of using cleavable solid phases for isolating nucleic acids |
| 02/23/2006 | WO2006019296A1 Means and methods for detecting and/or staging follicular lymphoma cells |
| 02/23/2006 | WO2006019155A1 Typing method for gene polymorphism |
| 02/23/2006 | WO2006019153A1 NONHUMAN ANIMAL WITH INHIBITED GdsmA GENE FUNCTION AND PROMOTED OR INHIBITIED CANCERATION-ASSOCIATED GENE FUNCTION |
| 02/23/2006 | WO2006019127A1 Method for capturing nucleic acid using divalent metal ion |
| 02/23/2006 | WO2006019065A1 METHOD OF ASSAYING α1,4-N-ACETYLGLUCOSAMINE TRANSFERASE (α4GnT) mRNA |
| 02/23/2006 | WO2006019037A1 Method of judging liver fibrosis stage |
| 02/23/2006 | WO2006018981A1 Dna chip manufacturing method, manufacturing system, hybridization detection method, detection system, substrate treatment device, and substrate treatment method |
| 02/23/2006 | WO2006018849A2 Non-invasive prenatal genetic diagnosis using transcervical cells |
| 02/23/2006 | WO2006018811A1 A bio-electronic device |
| 02/23/2006 | WO2006018643A2 Electrochemical sensors |
| 02/23/2006 | WO2006018572A2 Method for labeling and purifying nucleic acids of interest present in a biological sample to be treated in a single reaction vessel |
| 02/23/2006 | WO2006018544A1 Composition containing a thiophenic or benzothiophenic compound and exhibiting a pump nora inhibiting activity |
| 02/23/2006 | WO2006018425A2 Multiphase biocompatible semi-permeable membrane for biosensors |
| 02/23/2006 | WO2006018290A2 Method and kit for diagnosis of a cancerous disease method for determining the reaction of a patient to the treatment for a cancerous disease medicament for the prophylaxis or treatment of a cancerous disease |
| 02/23/2006 | WO2006018259A2 Method of screening for a carnitine transporter agonist or antagonist and its uses |
| 02/23/2006 | WO2006018243A1 Method for the analysis of methylated dna |
| 02/23/2006 | WO2006018164A2 Fluorescence-based kinetic determination of transglutaminase activity |
| 02/23/2006 | WO2006018049A1 Surface display expression system |
| 02/23/2006 | WO2006018023A2 Disease risk estimating method using sequence polymorphisms in a specific region of chromosome 19 |
| 02/23/2006 | WO2006017942A1 Methods of diagnosis or detection using three-dimensional analysis |
| 02/23/2006 | WO2006003439A3 Method for stabilising reagents which are useful for nucleic acid amplification |
| 02/23/2006 | WO2005118873A3 Compositions and methods for detecting open chromatin and for genome-wide chromatin state profiling |
| 02/23/2006 | WO2005118835A3 Cell lines and methods for evaluating integrating polynucleotides |
| 02/23/2006 | WO2005113827A3 Construction of live attenuated shigella vaccine strains that express cfa/i antigens (cfab and cfae) and the b subunit of heat-labile enterotoxin (ltb) from enterotoxigenic e. coli |
| 02/23/2006 | WO2005113801A3 Identification and characterization of a subset of glioblastomas sensitive to treatment with imatinib |
| 02/23/2006 | WO2005083116A3 Detection of nucleic acids |
| 02/23/2006 | WO2005069771A3 Small molecule antagonists of bcl-2 family proteins |
| 02/23/2006 | WO2005056002A3 Use of inductors of the degradation pathway of gamma-butyrolactone for inactivating the homoserine lactone n-acyl signal of gram-negative pathogenic bacteria |
| 02/23/2006 | WO2005052128A3 Mrna transfected antigen presenting cells |
| 02/23/2006 | WO2005045002A3 Nitrite-oxidizing bacteria and methods of using and detecting the same |
| 02/23/2006 | WO2005044997A3 Identification of novel targets for radio sensitization using a genomic-based radiation sensitivity classifier |
| 02/23/2006 | WO2005040342A3 Cleavage of rna by restriction endonucleases |
| 02/23/2006 | WO2005030928A3 PORCINE INVARIANT CHAIN PROTEIN, FULL LENGTH cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION |
| 02/23/2006 | WO2005028666A3 Determining kinase specificity |
| 02/23/2006 | WO2005016257A3 Process of making flowable hemostatic compositions and devices containing such compositions |
| 02/23/2006 | WO2005004988A3 Compositions and methods relating to novel compounds and targets thereof |
| 02/23/2006 | WO2004074310A3 Mycobacterial diagnostics |
| 02/23/2006 | WO2004071464A3 Diagnostic application of differentially-expressed genes in lympho-hematopoietic stem cells |
| 02/23/2006 | WO2004011670A3 Methods and compositions for nad(p)(h) oxidases |
| 02/23/2006 | WO2003091690A3 Cancer-associated nucleic acids and polypeptides |
| 02/23/2006 | WO2003089585A3 Methods of use of the enzymes of mycothiol synthesis |
| 02/23/2006 | WO2003072732A3 Methods of making hypermutable cells using pmsr homologs |
| 02/23/2006 | WO2003070889A3 Prostate specific genes and the use thereof in design or therapeutics |
| 02/23/2006 | WO2003027236A3 Systems, methods and kits for remote genetic analysis and consultation |
| 02/23/2006 | US20060041955 Marker-assisted selection of gene alleles that impart disease-resistance; resistance alleles of frogeye leaf spot resistance gene (Rcs3), brown stem rot resistance gene 1 (Rbs1), brown stem rot resistance gene 2 (Rbs2) and brown stem rot resistance gene 3 (Rbs3) |
| 02/23/2006 | US20060041954 Using fusarium resistant allelic profiles (SATT166 and SATT513) as evaluative tools in production disease resistant soybeans |
| 02/23/2006 | US20060041951 detecting at least one allelic form of a polymorphic simple sequence repeat (SSR) or a single nucleotide polymorphism (SNP); genetic engineered plant display tolerance or improved tolerance to Phytophthora root rot infection; employing a polymerase chain reaction (PCR) or ligase chain reaction (LCR) |
| 02/23/2006 | US20060041387 Smart microarray cancer detection system |
| 02/23/2006 | US20060041058 combined with bioactive agents for a variety of purposes including drug delivery and conjugation to one member of a binding pair for use in an assay |
| 02/23/2006 | US20060040881 Modulators of coagulation factors |
| 02/23/2006 | US20060040867 Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections |
| 02/23/2006 | US20060040411 Light-controlled electrokinetic assembly of particles near surfaces |
| 02/23/2006 | US20060040382 Tagged epitope protein transposable element |
| 02/23/2006 | US20060040378 Device and method for quantitatively determining an analyte, a method for determining an effective size of a molecule, a method for attaching molecules to a substrate, and a device for detecting molecules |
| 02/23/2006 | US20060040371 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 02/23/2006 | US20060040370 Purified thermostable pyrococcus furiosus dna polymerase i |
| 02/23/2006 | US20060040360 Adipocyte complement related protein homolog zacrp7 |
| 02/23/2006 | US20060040359 Oxidation-reduction sensitive green fluorescent protein variants |
| 02/23/2006 | US20060040358 IGF-1 receptor interacting proteins |
| 02/23/2006 | US20060040340 Microorganism specimen storage, hydrating, transfer and applicator device |
| 02/23/2006 | US20060040339 Method of constructing a calibration curve in microorganism assay |
| 02/23/2006 | US20060040338 Pharmacological profiling of drugs with cell-based assays |
| 02/23/2006 | US20060040337 Method of diagnosis of pregnancy-related complications |
| 02/23/2006 | US20060040336 Containing an acetylated substrate peptide labeled with a substance which emits a signal; and a peptidase whose peptide-cleaving activity changes upon an acetylation level of the substrate peptide. |
| 02/23/2006 | US20060040335 Diagnostic and screening methods and kits associated with proteolytic activity |
| 02/23/2006 | US20060040334 Method for characterising analytes |
| 02/23/2006 | US20060040333 Blood glucose monitoring kit |
| 02/23/2006 | US20060040331 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 02/23/2006 | US20060040330 Method of cancer screening |
| 02/23/2006 | US20060040329 CXCL10-based diagnosis and treatment of respiratory illnesses |
| 02/23/2006 | US20060040317 Recombinant Corynebacteria glutamicum in which expression of endogenous mqo gene coding for malate quinone oxidoreductase is eliminated by mutagenesis; Escherichia coli strain DH5alphamcr/pXK99Emobmqo (=DH5 alpha mcr/pXK99Emobmqo); especially L-lysine |
| 02/23/2006 | US20060040316 Using transforming growth factor-beta -activated kinase-1 (TAK-1) and TAK1 binding protein 1(TAB-1) as evaluative tool in detection of modulators of interleukin and tumor necrosis factor activities |
| 02/23/2006 | US20060040315 Methods for detecting neurological disorders |
| 02/23/2006 | US20060040314 Methods for screening polypeptides |
| 02/23/2006 | US20060040313 Human chemokine beta-9 |
| 02/23/2006 | US20060040312 Uses of kappa-conotoxin PVIIA |
| 02/23/2006 | US20060040311 Integrated cartridge for sample manipulation |
| 02/23/2006 | US20060040310 Epitope testing using soluble HLA |
| 02/23/2006 | US20060040309 Mesoscale polynucleotide amplification analysis |
| 02/23/2006 | US20060040308 nucleosides or oligonucleotide attached to solid supports; antisense agents |
| 02/23/2006 | US20060040307 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 02/23/2006 | US20060040306 81588 methods and compositions of human proteins and uses thereof |
| 02/23/2006 | US20060040305 Non-invasive prenatal genetic diagnosis using transcervical cells |
| 02/23/2006 | US20060040304 Biallelic markers related to genes involved in drug metabolism |
| 02/23/2006 | US20060040303 Reaction mixture for positioning a reaction vessel relative to a detection unit |
| 02/23/2006 | US20060040302 Methods of classifying, diagnosing, stratifying and treating cancer patients and their tumors |
| 02/23/2006 | US20060040301 Diagnosing source of local inflammation; from a clinical synovial fluid sample obtained from a site of local inflammation analysis of white cells present in known conditions can be used to differentiate between inflammation due to bacterial infection, arthritis or gout |
| 02/23/2006 | US20060040300 Method for nucleic acid isolation and amplification |
| 02/23/2006 | US20060040299 Cleavage of nucleic acids |
| 02/23/2006 | US20060040298 Rhesus monkey NURR1 nuclear receptor |
| 02/23/2006 | US20060040297 Methods of amplifying and sequencing nucleic acids |
| 02/23/2006 | US20060040296 Determining in a sample from the diabetic patient presence of a polypeptide comprising (Thrombin-Activable Fibrinolysis Inhibitor, TAFI); stroke, transitory ischemic attack, atherosclerotic cerebrovascular disease and/or coronary heart disease; cardiovascular disorders |
| 02/23/2006 | US20060040295 Novel allelic variant of CYP2C19 associated with drug metabolism |
| 02/23/2006 | US20060040294 Cleavage of nucleic acids |